SCHEMBL1474915

SCHEMBL1474915

O=C(CCc1cccnc1)Nc1cc(-c2ccco2)on1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.60
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
NPC1 O15118 3/20 0.60
KDM4E B2RXH2 2/20 0.60
PKM P14618 1/20 0.60
HTT P42858 1/20 0.60
HSD17B10 Q99714 2/20 0.55
ALOX15 P16050 1/20 0.55
SCD5 Q86SK9 2/20 0.49
RAB9A P51151 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NAMPT P43490 3/20 0.46
PSMB8 P28062 1/20 0.46
MKNK1 Q9BUB5 1/20 0.46
TSHR P16473 2/20 0.46
MAPT P10636 1/20 0.46
TNKS2 Q9H2K2 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1474923 0.87 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL1475763 0.87 SMN1; SMN2 (0.60) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL1474513 0.85 NPC1 (0.64) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL1475156 0.82 KMT2A (0.72) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL1474264 0.79 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL1474696 0.78 MAPT (0.50) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL30087181 0.78 NPC1 (0.80) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL1178360 0.78 NPC1 (0.80) ALDH1A1MEN1KMT2ANPC1KDM4E
SCHEMBL5017612 0.77 ADORA2A (0.66) MEN1KMT2AKDM4EHSD17B10SMN1; SMN2
SCHEMBL1474478 0.75 NPC1 (1.00) ALDH1A1MEN1KMT2ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1971600-B1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK BIOPHARMACEUTICALS CO LTD (KR) 2013-08-21 EP claimed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US claimed
EP-1971600-B1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK BIOPHARMACEUTICALS CO LTD (KR) 2013-08-21 EP disclosed
EP-1971600-B1 ISOXAZOLE DERIVATIVES AND USE THEREOF SK BIOPHARMACEUTICALS CO LTD (KR) 2013-08-21 EP disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-7915297-B2 Isoxazole derivatives and use thereof SK HOLDINGS CO., LTD. (KR) 2011-03-29 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed
US-20090131336-A1 Isoxazole Derivatives and Use Thereof SK BIOPHARMACEUTICALS CO., LTD. (KR) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131336-A1 Isoxazole Derivatives and Use Thereof WNT3A, WNT1, WNT3 ALDH1A1 706/4885MEN1 4845/4885KMT2A 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.